GeneDx Holdings (WGS) Profit After Tax (2020 - 2026)
GeneDx Holdings has reported Profit After Tax over the past 7 years, most recently at -$63.3 million for Q1 2026.
- Quarterly Profit After Tax fell 869.77% to -$63.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$77.8 million through Mar 2026, down 101.7% year-over-year, with the annual reading at -$21.0 million for FY2025, 59.8% up from the prior year.
- Profit After Tax was -$63.3 million for Q1 2026 at GeneDx Holdings, down from -$17.7 million in the prior quarter.
- Over five years, Profit After Tax peaked at $10.8 million in Q2 2025 and troughed at -$308.8 million in Q4 2022.
- The 5-year median for Profit After Tax is -$29.2 million (2024), against an average of -$50.7 million.
- Year-over-year, Profit After Tax skyrocketed 137.05% in 2025 and then plummeted 869.77% in 2026.
- A 5-year view of Profit After Tax shows it stood at -$308.8 million in 2022, then skyrocketed by 91.65% to -$25.8 million in 2023, then surged by 121.1% to $5.4 million in 2024, then plummeted by 424.86% to -$17.7 million in 2025, then plummeted by 258.41% to -$63.3 million in 2026.
- Per Business Quant, the three most recent readings for WGS's Profit After Tax are -$63.3 million (Q1 2026), -$17.7 million (Q4 2025), and -$7.6 million (Q3 2025).